Procedure for Developing a Stability Testing Plan for Global Compliance
1) Purpose
The purpose of this SOP is to define the procedure for preparing a comprehensive stability testing plan that meets the requirements of various global regulatory authorities, including the US FDA, EMA, and WHO. This plan ensures that drug products maintain their quality, safety, and efficacy throughout their intended shelf life.
2) Scope
This SOP applies to all personnel involved in the planning, execution, and documentation of stability testing for drug products intended for global markets.
3) Responsibilities
Regulatory Affairs Team: Responsible for understanding and incorporating global regulatory requirements into the stability testing plan.
Stability Study Team: Responsible for designing and executing stability studies as per the approved plan.
Quality Assurance Team: Responsible for ensuring data integrity and compliance with global guidelines.
4) Procedure
4.1 Review of Regulatory Requirements
4.1.1 Review and understand stability
4.1.2 Ensure that the stability testing plan incorporates all relevant requirements.
4.2 Plan Development
4.2.1 Develop a comprehensive stability testing plan that includes storage conditions, testing intervals, and parameters to be tested.
4.2.2 Ensure the plan is reviewed and approved by relevant departments (QA, Regulatory
4.3 Plan Implementation
4.3.1 Execute the stability testing plan as per the approved protocol.
4.3.2 Collect and document all data accurately for future regulatory submissions.
5) Abbreviations, if any
FDA: US Food and Drug Administration
EMA: European Medicines Agency
WHO: World Health Organization
6) Documents, if any
6.1 Regulatory guidelines
6.2 Stability testing protocols
6.3 Stability reports
7) Reference, if any
US FDA, EMA, WHO Stability Testing Guidelines
8) SOP Version
Version 1.0